Skip to main content

Peer Review reports

From: Learning from sotorasib: risk of bias in confirmatory clinical studies of accelerated approved drugs and resolution strategies

Original Submission
20 Nov 2023 Submitted Original manuscript
26 Dec 2023 Reviewed Reviewer Report - Ali Raza Khaki
1 Jan 2024 Reviewed Reviewer Report
2 Jan 2024 Reviewed Reviewer Report
4 Feb 2024 Author responded Author comments - Ning Jiang
Resubmission - Version 2
4 Feb 2024 Submitted Manuscript version 2
16 Feb 2024 Author responded Author comments - Ning Jiang
Resubmission - Version 3
16 Feb 2024 Submitted Manuscript version 3
26 Apr 2024 Author responded Author comments - Ning Jiang
Resubmission - Version 4
26 Apr 2024 Submitted Manuscript version 4
29 Apr 2024 Author responded Author comments - Ning Jiang
Resubmission - Version 5
29 Apr 2024 Submitted Manuscript version 5
Publishing
30 Apr 2024 Editorially accepted
20 May 2024 Article published 10.1186/s12916-024-03414-y

You can find further information about peer review here.

Back to article page